Excess mortality attributable to chronic kidney disease. Results from the PIRP project (Q40396356)

20 September 2017

Excess mortality attributable to chronic kidney disease. Results from the PIRP project (English)

1 reference

20 September 2017

1 reference

1

0 references

author name string

Marcora Mandreoli

2

1 reference

20 September 2017

Paola Rucci

3

1 reference

20 September 2017

Maria Pia Fantini

4

1 reference

20 September 2017

Angelo Rigotti

5

1 reference

20 September 2017

Roberto Scarpioni

6

1 reference

20 September 2017

Antonio Santoro

7

1 reference

20 September 2017

26 October 2015

1 reference

20 September 2017

Journal of Nephrology

1 reference

20 September 2017

29

1 reference

20 September 2017

663-671

1 reference

20 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s40620-015-0239-4

20 September 2017

0 references

cites work

Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Appraising relative and excess mortality in population-based studies of chronic diseases such as end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Risk prediction models for patients with chronic kidney disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Long term outcomes following hospital admission for sepsis using relative survival analysis: a prospective cohort study of 1,092 patients with 5 year follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

A clinical stratification tool for chronic kidney disease progression rate based on classification tree analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Choosing the relative survival method for cancer survival estimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Testing for causality and prognosis: etiological and prognostic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Missing data: our view of the state of the art

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Multiple imputation using chained equations: Issues and guidance for practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Relative survival of transplant patients: quantifying surplus mortality among renal transplant recipients compared with the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Mortality in the Veneto population on renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Survival trends in ESRD patients compared with the general population in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Chronic renal disease and risk of cardiovascular morbidity-mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Relation between kidney function, proteinuria, and adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Serum phosphate and mortality in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0239-4

Survival in patients treated by long-term dialysis compared with the general population

21 January 2018

1 reference

12 December 2020

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

12 December 2020

The relative survival rate: a statistical methodology

1 reference

12 December 2020

Relative survival: what can cardiovascular disease learn from cancer?

1 reference

12 December 2020

Impact of comorbidities on mortality in managed care patients with CKD

1 reference

12 December 2020

10.1007/S40620-015-0239-4

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference